Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-041725

Director sold 10,000 shares at $34.63 ($346,300)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lingnau Lutz Director 2019-07-08 Option exercise +10,000 $9.24 $92,400 33,200 D: show line 1 in the form
Lingnau Lutz Director 2019-07-08 Sale −10,000 $34.63 $346,300 23,200 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $34.63 · $346,300

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lingnau Lutz Director 2019-07-08 Option exercise · Stock Option −10,000 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…